Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Changes in SHBG levels don't predict diabetes risk reduction.

Dutasteride reduces DHT more effectively than finasteride.

Migrants from certain regions had a higher risk of COVID-19 than Spaniards.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Mesotherapy might help reduce fat in specific areas for those close to their ideal weight, but more research and care are needed to ensure safety.

Early balding at 40 increases prostate cancer risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

WNT10A and EBF1 interaction affects hair growth in male-pattern baldness.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Scalp lifting surgery can safely and effectively reduce baldness if done with careful planning and proper technique.

Adding a topical agent to IPL improves hair reduction and satisfaction without extra side effects.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The combined treatment with engineered bacteria and yellow LED light improved wound healing in mice.

Obesity worsens skin health and losing weight can improve skin conditions.

Hair loss is significantly linked to lower levels of certain genes in hair follicles.

Diabetes may lower the risk of prostate cancer.

Using enzymes with laser hair removal may reduce unwanted hair growth better than laser alone.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.